)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Genetic Signatures
Genetic Signatures (GSS) investor relations material
Genetic Signatures H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary25 Feb, 2026
Executive summary
Revenue increased to $8.7 million for 1H FY26, up from $8.5 million year-over-year, driven by steady Australian sales and growth in the U.S. and EMEA.
Gross profit declined to $4.8 million, with gross margin down to 55.7% from 58.8% due to higher consumables and raw material costs, especially for respiratory kits.
Underlying operating loss improved to $6.4 million from $8.4 million, aided by R&D tax incentive income, cost reductions, and improved other income.
Cash and cash equivalents stood at $29.9 million at 31 December 2025, with cash burn of approximately $7 million in the half and improved working capital.
Leadership changes included a new CEO, interim Managing Director, and CTO, with a focus on U.S. market expansion, cost discipline, and leveraging proprietary 3base technology.
Financial highlights
Revenue of $8.7 million, up from $8.5 million in 1H FY25, with growth in the U.S., U.K., and EMEA, driven by higher gastroenteric and respiratory testing.
Gross profit margin declined to 55.7% from 58.8% due to increased consumables costs.
Underlying operating loss improved to $6.4 million from $8.4 million, with prior period impacted by a $6.8 million non-recurring impairment.
Cash used in operations was $5.2 million, offset by a $4.4 million R&D incentive grant.
Net assets declined to $44.1 million at 31 December 2025.
Outlook and guidance
Australian sales expected to remain steady; focus on U.S. and EMEA expansion and customer base growth.
Emphasis on cost discipline, revenue acceleration, and AI as a core enabler.
New CEO to deliver a 90-day plan to reset performance and drive growth.
Ongoing development of next-generation instruments and automation to meet U.S. lab needs.
Advisors appointed to review capital management and deliver shareholder value.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Genetic Signatures earnings date
H2 202624 Aug, 2026
Genetic Signatures
Next Genetic Signatures earnings date
H2 202624 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Genetic Signatures Limited is a biotechnology company specializing in the development of molecular diagnostic solutions. The company focuses on creating innovative tests for the rapid detection of infectious diseases, leveraging its proprietary 3Base technology to improve accuracy and reduce diagnostic times. Genetic Signatures’ products are designed for use in clinical laboratories and hospitals, providing solutions for identifying pathogens responsible for conditions such as respiratory, gastrointestinal, and central nervous system infections. Genetic Signatures Limited is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage